Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling. [electronic resource]
Producer: 20180125Description: 334-344 p. digitalISSN:- 1872-7549
- Animals
- Benzamides -- pharmacology
- Benzoxazines -- pharmacology
- Cannabinoid Receptor Agonists -- pharmacology
- Carbamates -- pharmacology
- Cognitive Dysfunction -- drug therapy
- Fatty Acids -- metabolism
- Glycogen Synthase Kinase 3 -- metabolism
- Long-Term Potentiation -- drug effects
- Male
- Maze Learning -- physiology
- Mixed Function Oxygenases -- antagonists & inhibitors
- Morpholines -- pharmacology
- Naphthalenes -- pharmacology
- Neuroprotective Agents -- pharmacology
- Phosphatidylinositol 3-Kinases -- metabolism
- Proto-Oncogene Proteins c-akt -- metabolism
- Rats, Sprague-Dawley
- Receptors, Cannabinoid -- drug effects
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.